BIOVENTUS INC. — Earnings
Most recent reported period: FY2025 (Q4) (filed for period ending 2025-12-31) · sourced from SEC EDGAR
Recent earnings · last 8 quarters
| Quarter end | Revenue | YoY | Net Income | YoY | Op. Margin |
|---|---|---|---|---|---|
| 2025-12-31 | $158M | ↑+2.8% | $15M | — | 12.3% |
| 2025-09-27 | $139M | ↓-0.2% | $3M | ↑+161.1% | 8.1% |
| 2025-06-28 | $148M | ↓-2.4% | $7M | ↑+129.0% | 12.4% |
| 2025-03-29 | $124M | ↓-4.3% | $-3M | ↑+46.1% | 3.9% |
| 2024-12-31 | $154M | ↑+13.5% | — | — | — |
| 2024-09-28 | $139M | ↑+15.0% | $-5M | ↑+29.3% | 2.6% |
| 2024-06-29 | $151M | ↑+10.3% | $-26M | ↓-597.7% | -20.8% |
| 2024-03-30 | $129M | ↑+8.7% | $-5M | ↑+96.5% | 3.8% |
Analyst consensus estimates (EPS / Revenue) and implied move from options will land in a follow-up wave. For now, YoY-vs-prior-year-quarter is the surprise proxy.
Last earnings · FY2025 (Q4)
Earnings surprise · last 8 quarters
YoY % change · proxy for analyst surprise until estimates landEPS history · last 10 fiscal years
diluted, GAAP, annualNote: EPS reflects WEIGHTED-AVERAGE diluted shares for each fiscal year. Pre-stock- split values can blow up the early bars if SEC's XBRL data isn't split-adjusted — flagged as a known limitation; cumulative split-adjustment is a follow-up.
Margin trends · 26 quarters
margin trajectory tells the operating-leverage storyGo deeper
BVS Sankey — flow of dollars
See how revenue waterfalls through every line item to net income for the latest reported quarter, with prior-period comparison.
Open SankeyBVS Key Metrics — EPS, ROE, ROIC
10 CFA-grade fundamental ratios — EPS, BVPS, ROE, ROA, ROIC, Debt/Equity, Current Ratio. Compare across years.
Open Key Metrics